Advanced search
Publication Cover
Infection and Drug Resistance Volume 13, 2020 - Issue
Submit an article Journal homepage
113
Views
0
CrossRef citations to date
0
Altmetric
Original Research

No Evidence for Ceftobiprole-Induced Immune Hemolytic Anemia in Three Phase 3 Clinical Trials

Kamal Hamed1 Basilea Pharmaceutica International Ltd., Basel, SwitzerlandCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-1896-9736
ORCID Icon,
Tatiana Wiktorowicz1 Basilea Pharmaceutica International Ltd., Basel, Switzerland
&
Maziar Assadi Gehr1 Basilea Pharmaceutica International Ltd., Basel, Switzerland
Pages 3209-3215 | Published online: 16 Sep 2020

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.